DermAbiotech Company
DermAbiotech develops innovative targeted therapies for acute T cell-mediated inflammatory diseases.
Founded Date:
2014-01-01
Employee Number:
1-10
Headquarters:
Plan-les-ouates, Geneve, Switzerland, Europe
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Investors:
Eclosion SA, Venture Kick
Ipo Status:
private
City:
Plan-les-Ouates
Region:
Geneve
Country:
Switzerland
Founders:
Yann Dean